Fludarabine/melphalan conditioning for allogeneic stem cell transplantation (SCT) in elderly patients with AML/MDS

被引：0
|
作者：
Kennedy, GA
Butler, J
Durrant, S
Hill, GR
Western, R
Morton, J
机构：
[1] Royal Brisbane & Womens Hosp, Div Oncol, Brisbane, Qld, Australia
[2] Queensland Inst Med Res, Brisbane, Qld 4006, Australia
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5410
引用
收藏
页码：438B / 439B
页数：2
相关论文
共 50 条
  • [1] Fludarabine and treosulfan conditioning for allogeneic stem cell transplantation (SCT) in patients with AML and MDS not eligible for standard myeloablative conditioning: the role of treosulfan dose
    Shimoni, A.
    Peccatori, J.
    Shem-Tov, N.
    Lo Russo, A.
    Yerushalmi, R.
    Bernardi, M.
    Nagler, A.
    Ciceri, F.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S220 - S220
  • [2] Comparable outcomes for Fludarabine/TBI versus Fludarabine/Treosulfan conditioning prior to allogeneic stem cell transplantation (Allo-SCT) in AML and MDS patients
    Berning, P.
    Kolloch, L.
    Reicherts, C.
    Call, S.
    Marx, J.
    Floeth, M. P.
    Esseling, E.
    Schliemann, C.
    Lenz, G.
    Stelljes, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 140 - 140
  • [3] FLUDARABINE AND TREOSULFAN CONDITIONING FOR ALLOGENEIC STEM-CELL TRANSPLANTATION IN PATIENTS WITH AML AND MDS NOT ELIGIBLE FOR STANDARD MYELOABLATIVE CONDITIONING
    Shimoni, A.
    Crotta, A.
    Shem-Tov, N.
    Peccatori, J.
    Yerushalmi, R.
    Bernardi, M.
    Nagler, A.
    Ciceri, F.
    HAEMATOLOGICA, 2012, 97 : 177 - 177
  • [4] IMPROVED OUTCOMES OF PATIENTS WITH AML/MDS UNDERGOING HAPLOIDENTICAL STEM CELL TRANSPLANTATION USING FLUDARABINE, MELPHALAN AND THIOTEPA CONDITIONING CHEMOTHERAPY
    Ciurea, S. O.
    Quareshi, S.
    Rondon, G.
    McMannis, J.
    Pesoa, S.
    Cano, P.
    Fernandez-Vina, M.
    Giralt, S.
    de Lima, M.
    Champlin, R. E.
    Gajewski, J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 50 - 50
  • [5] Allogeneic Transplantation in Elderly Patients with AML and MDS Comparing Reduced-Intensity Conditioning with Flamsa-Busulfan Versus Fludarabine/BCNU/Melphalan
    Engel, Nicole
    Hill, Wolfgang
    Fritsch, Susanne
    Prevalsek, Dusan
    Zoellner, Anna-Katharina
    Hubmann, Max
    Buecklein, Veit
    Hausmann, Andreas
    Ledderose, Georg
    Kolb, Hans-Jochem
    Hiddemann, Wolfgang
    Tischer, Johanna
    BLOOD, 2014, 124 (21)
  • [6] Allogeneic Transplantation in Elderly Patients with AML and MDS Comparing Reduced-Intensity Conditioning with FLAMSA-Busulfan versus Fludarabine/BCNU/Melphalan
    Fritsch, S.
    Engel, N.
    Hill, W.
    Prevalsek, D.
    Zoellner, A.
    Hubmann, M.
    Buecklein, V.
    Hausmann, A.
    Ledderose, G.
    Kolb, H-J
    Schmid, C.
    Hiddemann, W.
    Tischer, I.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S480 - S481
  • [7] Comparable Survival for Fludarabine and Treosulfan Vs. Fludarabine and TBI As Conditioning Regimens in Patients with AML and MDS Undergoing Allogeneic Stem Cell Transplantation
    Kolloch, Lina
    Berning, Philipp
    Reicherts, Christian
    Call, Simon
    Marx, Julia
    Floeth, Matthias
    Esseling, Eva
    Ronnacker, Julian
    Mikesch, Jan-Henrik
    Schliemann, Christoph
    Lenz, Georg
    Stelljes, Matthias
    BLOOD, 2023, 142
  • [8] Pharmacokinetically guided, once-daily intravenous busulfan in combination with fludarabine for elderly AML/MDS patients as a conditioning regimen for allogeneic stem cell transplantation
    Chikako Ohwada
    Shingo Yamazaki
    Katsuhiro Shono
    Kensuke Kayamori
    Yutaro Hino
    Nagisa Oshima-Hasegawa
    Tomoya Muto
    Shokichi Tsukamoto
    Shio Mitsukawa
    Yusuke Takeda
    Naoya Mimura
    Masahiro Takeuchi
    Tohru Iseki
    Masahiro Onoda
    Akira Yokota
    Takaaki Suzuki
    Itsuko Ishii
    Chiaki Nakaseko
    Emiko Sakaida
    International Journal of Hematology, 2021, 114 : 664 - 673
  • [9] Pharmacokinetically guided, once-daily intravenous busulfan in combination with fludarabine for elderly AML/MDS patients as a conditioning regimen for allogeneic stem cell transplantation
    Ohwada, Chikako
    Yamazaki, Shingo
    Shono, Katsuhiro
    Kayamori, Kensuke
    Hino, Yutaro
    Oshima-Hasegawa, Nagisa
    Muto, Tomoya
    Tsukamoto, Shokichi
    Mitsukawa, Shio
    Takeda, Yusuke
    Mimura, Naoya
    Takeuchi, Masahiro
    Iseki, Tohru
    Onoda, Masahiro
    Yokota, Akira
    Suzuki, Takaaki
    Ishii, Itsuko
    Nakaseko, Chiaki
    Sakaida, Emiko
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 114 (06) : 664 - 673
  • [10] Allogeneic Stem Cell Transplantation (SCT) in Elderly Patients with AML and ALL: Chance of Cure?
    Arnold, Renate
    Vuong, Lam
    Jehn, Christian
    Na, Il-Kang
    Waldhueter, Nils
    Penter, Livius
    Shinawi, Mohammad Ahmed A.
    Blau, Wolfgang-Igor
    Penack, Olaf
    Terwey, Theis
    Hemmati, Philipp
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S197 - S197
12345